Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV vs SC Interleukin-2 in Metastatic Renal Cell Carcinoma
NCT00018941Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 1991
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of aldesleukin in metastatic renal cell carcinoma (mRCC), sponsored by National Cancer Institute. Started Apr 1991; status: completed.
02
Drugs
aldesleukin
03
Conditions
metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on NCT00018941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00018941.